BiotechTube
Home/Kanvas Biosciences/Matt Cheng
MC

Matt Cheng

CEO

Kanvas Biosciences

Therapeutic Areas

Oncology

Kanvas Biosciences Pipeline

DrugIndicationPhase
KAN-001Checkpoint Refractory CancersPreclinical